loadpatents
name:-0.01577091217041
name:-0.0096321105957031
name:-0.0011298656463623
Vallera; Daniel A. Patent Filings

Vallera; Daniel A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vallera; Daniel A..The latest application filed is for "nk engager molecules and methods of use thereof".

Company Profile
0.12.14
  • Vallera; Daniel A. - Minneapolis MN
  • Vallera; Daniel A. - St. Louis Park MN
  • Vallera; Daniel A. - Richfield MN
  • Vallera, Daniel A. - St. Louis MN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Nk Engager Molecules And Methods Of Use Thereof
App 20210388093 - Miller; Jeffrey S. ;   et al.
2021-12-16
Single-chain variable fragment anti-CD133 antibodies and uses thereof
Grant 11,098,109 - Vallera August 24, 2
2021-08-24
Single-chain Variable Fragment Anti-cd133 Antibodies And Uses Thereof
App 20170240627 - Ohlfest; John R. ;   et al.
2017-08-24
Methods And Compositions For Bi-specific Targeting Of Cd19/cd22
App 20170137513 - Vallera; Daniel A. ;   et al.
2017-05-18
Single-chain variable fragment anti-CD133 antibodies and uses thereof
Grant 9,624,303 - Ohlfest , et al. April 18, 2
2017-04-18
Single-chain Variable Fragment Anti-cd133 Antibodies And Uses Thereof
App 20160215058 - Ohlfest; John R. ;   et al.
2016-07-28
Methods and compositions for bi-specific targeting of CD19/CD22
Grant 9,371,386 - Vallera , et al. June 21, 2
2016-06-21
Single chain variable fragment anti-CD133 antibodies and uses thereof
Grant 9,249,225 - Ohlfest , et al. February 2, 2
2016-02-02
Receptor-targeting Reagents
App 20160000868 - Vallera; Daniel A.
2016-01-07
Receptor-targeting reagents containing epidermal factor receptor-binding agents and IL-13 receptor-binding agents or IL-4 receptor-binding agents
Grant 9,155,798 - Vallera October 13, 2
2015-10-13
Single-chain Variable Fragment Anti-cd133 Antibodies And Uses Thereof
App 20130224202 - Ohlfest; John R. ;   et al.
2013-08-29
Methods And Compositions For Bi-specific Targeting Of Cd19/cd22
App 20120121614 - Vallera; Daniel A. ;   et al.
2012-05-17
Receptor-targeting Reagents
App 20110091460 - Vallera; Daniel A.
2011-04-21
Cell-mediated targeting of toxins to pathogenic cells
Grant 7,101,542 - Vallera , et al. September 5, 2
2006-09-05
DTAT fusion toxin
App 20050245448 - Vallera, Daniel A. ;   et al.
2005-11-03
DTAT fusion toxin
Grant 6,846,484 - Vallera , et al. January 25, 2
2005-01-25
DTAT fusion toxin
App 20030124147 - Vallera, Daniel A. ;   et al.
2003-07-03
Multimeric immunotoxins
Grant 6,492,498 - Vallera , et al. December 10, 2
2002-12-10
Radiolabeled immunotoxins
App 20020048550 - Vallera, Daniel A. ;   et al.
2002-04-25
Ex vivo treatment of allogeneic and xenogeneic donor T-cells containing compositions (bone marrow) using gp39 antagonists and use thereof
App 20020048579 - Noelle, Randolph J. ;   et al.
2002-04-25
Ex vivo treatment of allogeneic and xenogeneic donor T-cells containing compositions (bone marrow) using gp39 antagonists and use thereof
App 20020022020 - Noelle, Randolph J. ;   et al.
2002-02-21
Radiolabeled fusion toxins for cancer therapy
Grant 6,001,329 - Buchsbaum , et al. December 14, 1
1999-12-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed